241 related articles for article (PubMed ID: 16574224)
1. Carcinoembryonic antigen and related molecules in normal and transformed trophoblast.
Vićovac Lj; Bozić M; Bojić-Trbojević Z; Golubović S
Placenta; 2007; 28(2-3):85-96. PubMed ID: 16574224
[TBL] [Abstract][Full Text] [Related]
2. Expression of the human P2Y6 nucleotide receptor in normal placenta and gestational trophoblastic disease.
Somers GR; Bradbury R; Trute L; Conigrave A; Venter DJ
Lab Invest; 1999 Feb; 79(2):131-9. PubMed ID: 10068202
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases and their inhibitors in gestational trophoblastic diseases and normal placenta.
Vegh GL; Selcuk Tuncer Z; Fulop V; Genest DR; Mok SC; Berkowitz RS
Gynecol Oncol; 1999 Nov; 75(2):248-53. PubMed ID: 10525381
[TBL] [Abstract][Full Text] [Related]
4. Expression pattern alterations of syndecans and glypican-1 in normal and pathological trophoblast.
Crescimanno C; Marzioni D; Paradinas FJ; Schrurs B; Mühlhauser J; Todros T; Newlands E; David G; Castellucci M
J Pathol; 1999 Dec; 189(4):600-8. PubMed ID: 10629564
[TBL] [Abstract][Full Text] [Related]
5. Expression of melanoma cell adhesion molecule in intermediate trophoblast.
Shih IM; Kurman RJ
Lab Invest; 1996 Sep; 75(3):377-88. PubMed ID: 8804361
[TBL] [Abstract][Full Text] [Related]
6. Galectin-1 and galectin-3 in the trophoblast of the gestational trophoblastic disease.
Bozić M; Petronijević M; Milenković S; Atanacković J; Lazić J; Vićovac Lj
Placenta; 2004 Nov; 25(10):797-802. PubMed ID: 15451194
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemistry of choriocarcinoma: an aid in differential diagnosis and in elucidating pathogenesis.
Mao TL; Kurman RJ; Huang CC; Lin MC; Shih IeM
Am J Surg Pathol; 2007 Nov; 31(11):1726-32. PubMed ID: 18059230
[TBL] [Abstract][Full Text] [Related]
8. Expression of the Thomsen-Friedenreich antigen and of its putative carrier protein mucin 1 in the human placenta and in trophoblast cells in vitro.
Jeschke U; Richter DU; Hammer A; Briese V; Friese K; Karsten U
Histochem Cell Biol; 2002 Mar; 117(3):219-26. PubMed ID: 11914919
[TBL] [Abstract][Full Text] [Related]
9. Selective immunolabeling of early gestational cytotrophoblast and its neoplastic counterpart by the monoclonal antibody Ber-EP4.
Babury RA; Moscovic EA
Histol Histopathol; 1993 Apr; 8(2):323-8. PubMed ID: 8490260
[TBL] [Abstract][Full Text] [Related]
10. Expression of galectin-3 and carcinoembryonic antigen in the trophoblast of the gestational trophoblastic disease.
Bozić M; Golubović S; Petronijević M; Vićovac Lj
J BUON; 2004; 9(4):427-32. PubMed ID: 17415850
[TBL] [Abstract][Full Text] [Related]
11. [Immunohistochemical study on trophoblast subpopulations in normal pregnancy and trophoblastic disease].
Sasagawa M
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Oct; 37(10):2010-8. PubMed ID: 3001198
[TBL] [Abstract][Full Text] [Related]
12. New concepts in trophoblastic growth and differentiation with practical application for the diagnosis of gestational trophoblastic disease.
Shih IM; Kurman RJ
Verh Dtsch Ges Pathol; 1997; 81():266-72. PubMed ID: 9474880
[TBL] [Abstract][Full Text] [Related]
13. Human trophoblast cells express the immunomodulator progesterone-induced blocking factor.
Anderle C; Hammer A; Polgár B; Hartmann M; Wintersteiger R; Blaschitz A; Dohr G; Desoye G; Szekeres-Barthó J; Sedlmayr P
J Reprod Immunol; 2008 Oct; 79(1):26-36. PubMed ID: 18817979
[TBL] [Abstract][Full Text] [Related]
14. Placental Fas and Fas ligand expression in normal early, term and molar pregnancy.
Pongcharoen S; Searle RF; Bulmer JN
Placenta; 2004 Apr; 25(4):321-30. PubMed ID: 15028424
[TBL] [Abstract][Full Text] [Related]
15. P63 expression in gestational trophoblastic disease: correlation with proliferation and apoptotic dynamics.
Zhang HJ; Xue WC; Siu MK; Liao XY; Ngan HY; Cheung AN
Int J Gynecol Pathol; 2009 Mar; 28(2):172-8. PubMed ID: 19188816
[TBL] [Abstract][Full Text] [Related]
16. Differential gene expression pattern between normal human trophoblast and choriocarcinoma cell lines: downregulation of heat shock protein-27 in choriocarcinoma in vitro and in vivo.
Vegh GL; Fulop V; Liu Y; Ng SW; Tuncer ZS; Genest DR; Paldi-Haris P; Foldi J; Mok SC; Berkowitz RS
Gynecol Oncol; 1999 Dec; 75(3):391-6. PubMed ID: 10600295
[TBL] [Abstract][Full Text] [Related]
17. [Changes in gene expression profiles of hydatidiform mole and choriocarcinoma as compared with trophoblast hyperplasia].
Cui JQ; Shi YF; Zhou HJ; Li JQ
Zhonghua Zhong Liu Za Zhi; 2004 Dec; 26(12):727-31. PubMed ID: 15733390
[TBL] [Abstract][Full Text] [Related]
18. Progesterone-induced blocking factor (PIBF) and trophoblast invasiveness.
Miko E; Halasz M; Jericevic-Mulac B; Wicherek L; Arck P; Arató G; Skret Magierlo J; Rukavina D; Szekeres-Bartho J
J Reprod Immunol; 2011 Jun; 90(1):50-7. PubMed ID: 21632119
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of p57kip2, a maternally imprinted cdk inhibitor, in normal human placenta and gestational trophoblastic disease.
Chilosi M; Piazzola E; Lestani M; Benedetti A; Guasparri I; Granchelli G; Aldovini D; Leonardi E; Pizzolo G; Doglioni C; Menestrina F; Mariuzzi GM
Lab Invest; 1998 Mar; 78(3):269-76. PubMed ID: 9520940
[TBL] [Abstract][Full Text] [Related]
20. Bi-potential behaviour of cytotrophoblasts in first trimester chorionic villi.
Baczyk D; Dunk C; Huppertz B; Maxwell C; Reister F; Giannoulias D; Kingdom JC
Placenta; 2006; 27(4-5):367-74. PubMed ID: 15950280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
